MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 6.82
-0.16 (-2.29%)
At close: Mar 6, 2026
MaaT Pharma Revenue
MaaT Pharma had revenue of 2.43M EUR in the half year ending June 30, 2025, with 76.12% growth. This brings the company's revenue in the last twelve months to 3.92M, up 52.55% year-over-year. In the year 2024, MaaT Pharma had annual revenue of 3.22M with 44.34% growth.
Revenue (ttm)
3.92M
Revenue Growth
+52.55%
P/S Ratio
32.72
Revenue / Employee
60.34K
Employees
65
Market Cap
128.33M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adocia | 12.88M |
| Innate Pharma | 12.64M |
| ABIONYX Pharma | 4.33M |
| Sensorion | 5.65M |
| OSE Immunotherapeutics | 1.78M |
| Transgene | 7.58M |
| Cellectis | 70.36M |
| Valerio Therapeutics Société anonyme | 1.83M |